B-cell acute lymphoblastic leukemia pediatric · 7 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG AALL0932 protocol for standard-risk N/A - intrathecal component | — | R 69 336 | 133d | — | — | — | — | — |
COG AALL1131 protocol for Ph-like B-ALL (Dasatinib Arm) N/A - intrathecal component | — | R 54 093 | 84d | — | — | — | — | — |
COG AALL1131 protocol for VHR B-ALL N/A - intrathecal component | — | R 12 533 | 84d | — | — | — | — | — |
COG AALL1131 protocol for DS HR B-ALL N/A - intrathecal component | — | R 11 824 | 84d | — | — | — | — | — |
COG AALL1131 protocol for HR B-ALL N/A - intrathecal component | — | R 690 | 84d | — | — | — | — | — |
COG AALL1131 protocol Partial | — | — | — | — | — | — | — | — |
COG AALL1122 protocol Partial | BCR::ABL1 | — | — | — | — | — | — | — |
7 of 7 regimens shown